Ho presentato la mia candidatura online. La procedura ha richiesto 3 settimane. Ho sostenuto un colloquio presso Source Capital Group (Westport, CT) nel mese di ott 2019
Colloquio
This is this trimmed down version as my original version exceeded 5,000 words.
Disclaimer: although I haven’t gotten a formal offer... I’m fairly confident I’ll be getting one, as after I expressed my surprise at how unique this interview process was and that i was considering writing something on glassdoor, he responded with “make sure it’s accurate- and be transparent”
Some advice I can give you is take initiative. Offer to meet or interview with him in ways that fit his calendar. In his own words he’s “very difficult to to get in touch with (him).”
Whether or not this is done by design, idk- but it appears as if the more he becomes interested in you as a candidate, the easier it is to get in touch with him.
Anyway i received an email that was definitely sent to a lot of people via BCC, basically outlining the interview process which is:
- intro call
- 3 part question and answer interview
- case study
- in-person meeting with interviewer and team
Note, i did the interview and call at the same time. Although the interview is SO hard (described below), this goes back to the initiative component.
You still need to have a strong understanding of quantitative analysis and valuation, but (the third part especially) is more of a situational and the answers are more like “what would you do in this situation and why”
The case study for me was a public company who has an asset related to CAR-T therapy (i dont want to explain too much and ruin my chances of being selected)
Then you’re given an extensive list questionnaire that asks about the therapy itself and some qualitative business-related questions. Then you are given a ‘quantbook’ template that has boiler plates for DCF, comparable companies, key ratios and potential structures and dilution metrics
After filling all of that out, you then need to put together a writeup that has different sections to expand upon.. it’s very detailed
(Again not the exact question because i’m going from memory but...)
What type of therapy is being described:
It works by extracting T-Cells, genetically engineering them to target a tumor, then re-administering them into your body
Besides the obvious benefit of improving the safety profile and subjecting the patient to harmful side effects, what is a significant benefit for taking a *prophylactic* (KNOW WHAT THIS WORD MEANS) that prevents toxicity as a result of CAR-T therapy